Evaluation of the URIT-2900 Automated Hematology Analyzer for screening of thalassemia and hemoglobinopathies in Southeast Asian populations

Abstract

Background The effectiveness of the URIT-2900 Hematology Analyzer for screening of hemoglobinopathies commonly found in Southeast Asian populations was examined. Methods Appropriate cut-off values of MCV and MCH for screening of α 0 and β thalassemias were derived from the receiver operator characteristic curve conducted initially on 279 subjects with various thalassemia genotypes. Validation was performed additionally in a cohort of another unrelated 313 subjects. Results The best cut off values of MCV and MCH were found to be 78 fL and 27 pg, respectively. Using these cut off values in combination with the dichlorophenolindophenol test in screening of α 0 thalassemia, β thalassemia and Hb E in a cohort study revealed 100% sensitivity, 79.6% specificity, 80.0% positive predictive value and 100% negative predictive value. Conclusion The combined blood cell counting using the URIT-2900 Automated Hematology Analyzer and dichlorophenolindophenol test is suitable for population screening of thalassemia and hemoglobinopathies in Southeast Asia.